LATEST RESEARCH FINDINGS INDICATE THAT DRUG ELUTING STENTS (DES) REDUCE THE NEED FOR RE-INTERVENTION AFTER PTCA TO A GREATER EXTENT THAN BARE METAL STENTS (BMS)

Research and Markets has announced the addition of Drug Eluting Stents — Technology & Market Forecast to their offering The introduction of Drug Eluting Stents has dramatically impacted the market size and growth rates for coronary stents worldwide. It has also impacted the distribution of market shares across the industry.
Genetic Engineering News